FDA Inspection 1102880 — Eric Roselli, M.D.
The FDA completed an inspection of Eric Roselli, M.D. on September 19, 2019 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 19, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Cleveland, OH (United States)
Additional Details
Clinical Investigator (CI)